DNMT1 and ovarian cancer: Notably, Cacan et al. showed that in chemoresistant ovarian cancer, DNA hypermethylation and histone deacetylation, driven by HDAC1/HDAC3 and DNMT1, suppress immune co-stimulatory molecules while upregulating immunosuppressive PD-L1 [15].